First Trust Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $27.6M | Sell |
|
|||||
|
2025
Q2 | $39.8M | Sell |
|
|||||
|
2025
Q1 | $49.8M | Buy |
|
|||||
|
2024
Q4 | $20.4M | Sell |
|
|||||
|
2024
Q3 | $27M | Buy |
|
|||||
|
2024
Q2 | $23.8M | Buy |
|
|||||
|
2024
Q1 | $753K | Sell |
|
|||||
|
2023
Q4 | $5.23M | Buy |
|
|||||
|
2023
Q3 | $406K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $377K | Sell |
|
|||||
|
2022
Q4 | $5.08M | Sell |
|
|||||
|
2022
Q3 | $5.92M | Sell |
|
|||||
|
2022
Q2 | $13.1M | Buy |
|
|||||
|
2022
Q1 | $12.1M | Sell |
|
|||||
|
2021
Q4 | $19.6M | Buy |
|
|||||
|
2021
Q3 | $16.4M | Sell |
|
|||||
|
2021
Q2 | $20M | Sell |
|
|||||
|
2021
Q1 | $23.6M | Sell |
|
|||||
|
2020
Q4 | $30.4M | Buy |
|